Variant report
Variant | nsv970422 |
---|---|
Chromosome Location | chr7:119233323-119244802 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192264821 | chr7:119233817-119233818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563400626 | chr7:119233916-119233917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528843783 | chr7:119233949-119233950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141257989 | chr7:119233978-119233979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564510355 | chr7:119234031-119234032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184839285 | chr7:119234035-119234036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528378681 | chr7:119234063-119234064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79254327 | chr7:119234064-119234065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528538214 | chr7:119234117-119234118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571462871 | chr7:119234162-119234163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73719970 | chr7:119234165-119234166 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs73719971 | chr7:119234175-119234176 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs6971166 | chr7:119234197-119234198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145052501 | chr7:119234211-119234212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146803082 | chr7:119234215-119234216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs76743688 | chr7:119234224-119234225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140615528 | chr7:119234279-119234280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs150446194 | chr7:119234294-119234295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575704751 | chr7:119234403-119234404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368916192 | chr7:119234428-119234429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544801037 | chr7:119234465-119234466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541042952 | chr7:119234516-119234517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6975674 | chr7:119234557-119234558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376051854 | chr7:119234632-119234633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573702231 | chr7:119234674-119234675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542772065 | chr7:119234722-119234723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149212130 | chr7:119234791-119234792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34052356 | chr7:119234805-119234806 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73719972 | chr7:119234817-119234818 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35911298 | chr7:119234868-119234869 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545275835 | chr7:119234869-119234870 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565192111 | chr7:119234870-119234871 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530583951 | chr7:119234878-119234879 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550770249 | chr7:119234944-119234945 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189613368 | chr7:119234959-119234960 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533061031 | chr7:119234960-119234961 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs151168719 | chr7:119234970-119234971 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs180881220 | chr7:119234985-119234986 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573798647 | chr7:119234999-119235000 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs57199355 | chr7:119235034-119235035 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs566527102 | chr7:119235066-119235067 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12537312 | chr7:119235090-119235091 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs80104525 | chr7:119235134-119235135 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529506872 | chr7:119235152-119235153 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569551664 | chr7:119235235-119235236 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143410311 | chr7:119235244-119235245 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555123719 | chr7:119235301-119235302 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185978463 | chr7:119235303-119235304 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536349983 | chr7:119235354-119235355 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549640063 | chr7:119235392-119235393 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:119233800-119235800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr7:119234000-119235600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr7:119234000-119235600 | Enhancers | H1 Cell Line | embryonic stem cell |
4 | chr7:119234000-119236400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr7:119234200-119235600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr7:119234600-119235200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
7 | chr7:119234600-119235600 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr7:119234600-119235800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr7:119234600-119235800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr7:119234600-119235800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr7:119234600-119236200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr7:119234800-119236400 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr7:119235600-119236200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |